SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Biotech / MedicalCutera


Previous 10 Next 10 
To: Harshu Vyas who wrote (2)1/31/2024 6:35:06 PM
From: Harshu Vyas
   of 21
 
For those interested, from what I've gathered UK derms are charging about £4.5k for AviClear.

AviClear Acne Treatment | PHI Clinic London

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas2/1/2024 11:49:07 AM
   of 21
 
Taylor Harris was CFO of Zeltiq before it was acquired and failed to file timely a 10Q and 10K at that point, too. NT 10-K (sec.gov)

The difference being both were filed in less than two months after the notification. Cutera's 10Q was due over two-and-a-half months ago.

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas2/6/2024 12:58:37 PM
   of 21
 
Ok, so it seems the way CUTR's stock trades is simple. Big % gains on up days and stead losses on losing days. Problem is, that losing days occur all too frequently. Ironically, I had planned to cut my loss today if CUTR broke $2.3/sh.

These sort of setups are dangerous because they're so hard to play. Yesterday I had the impression that it was time to get out - the technicals looked pretty dire. And today the stock's up more than 15%. The chart now looks fine because its now bottomed twice in the last month at ~ $2.39 so there's some support there.

Who knows where this goes? I certainly don't have a clue.

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas2/27/2024 11:21:42 AM
   of 21
 
Cutera maintains its support at the $2.39 (ish) level. Problem, as I see it, is there is lots of resistance around $3 so we're stuck in a range for now. I've read online that earnings come out today (?) but I haven't seen any press release confirming that. It's not on their IR website, either.

Not too sure what to do. The silence is beginning to worry me. Have reached out to IR a few times. No response.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Harshu Vyas who wrote (7)2/28/2024 10:08:58 AM
From: Harshu Vyas
   of 21
 
My concern now is the silence from management and the IR team. No conference call has even been scheduled for 4Q earnings... why? In the prelim results, management said they would meet with investors privately. Does that mean no conference? Are they shrugging off analysts?

They still have to file a 10K and a 10Q, too. This wasn't a concern when I first invested, but it's slowly becoming one the longer this draws out.

I've emailed IR, but they haven't replied to me in the past. If the silence continues, I'll sell at a loss.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Harshu Vyas who wrote (8)2/28/2024 1:22:40 PM
From: Harshu Vyas
   of 21
 
Welp. It's broken support and we're into the $2.2s... what does the market know?

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas2/29/2024 10:38:51 AM
   of 21
 
Jeez, this stock is like a toxic girlfriend. No stability and a constant headache.

I don't recommend the stock... Even if it is undervalued. It's just not worth the pain. But I'm underwater and selling at a loss for no reason is stupid, so here I stubbornly remain.

Average price is $2.5. I sold my VFC shares last night to add. No excess cash. I'm all-in. And I just can't wait to get out and pick up my VFC shares again. Oh, how much I'd give to own quality companies!

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas3/1/2024 8:43:12 AM
   of 21
 
Ah, an answer. Finally.

Cutera to Announce Fourth Quarter and Full-Year 2023 Results on March 21, 2024 | Cutera Inc.

So they'll file their 10Q next week and the 10K will be delayed even after FY results, too.
They maintain that the reason for the delay is due to an inventory shortfall. Maybe it does take quite a long time.

(FWIW, I'm actually happy to see that they'll take the time to make sure their accounts are proper. Better to be accurate and honest than timely, imo.)

Put it in your calendar - Thursday March 21 2024.

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas3/5/2024 12:58:14 PM
   of 21
 
Before and After Acne Laser Results You Have to See to Believe (newbeauty.com)

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas3/6/2024 12:24:06 PM
   of 21
 
Based on the Company's current plans, the Company believes that its current cash and cash equivalents and anticipated cash flow from operations will be sufficient to meet its anticipated cash requirements for at least the next twelve months. If the Company's available cash resources and cash flow from operations are insufficient to satisfy its liquidity requirements including because of lower demand for its products or the realization of other risks described in its Annual Report, the Company may be required to raise additional capital through the issuances of additional equity or convertible debt securities, enter into a credit facility or another form of third-party funding or seek other debt financing.The various ways the Company could raise additional capital carry potential risks. If the Company raises funds by issuing equity securities, dilution to its stockholders would result. If the Company raises funds by issuing debt securities, those debt securities would have rights, preferences and privileges senior to those of holders of the Company's common stock. The terms of debt securities issued or borrowings pursuant to a credit agreement could impose significant restrictions on the Company's operations and present the risk of default. If the Company raises funds through collaborations or licensing arrangements, the Company may be required to relinquish significant rights to its technologies or products or grant licenses on terms that are not favorable to the Company.If the Company is unable to obtain adequate financing or financing on terms satisfactory to the Company, if the Company requires it, the Company's ability to continue to pursue its business objectives and to respond to business opportunities, challenges, or unforeseen circumstances could be significantly limited, and could have a material adverse effect on the Company's business, financial condition, results of operations and prospects.


This additional risk factor is what worries me. The idea that they know they need additional financing. At current levels, convertible notes would kill the stock, but may be the best choice as it buys them time. I'd say management need to get the stock higher, though, before they refi their convertibles.

Vanilla equity would crash the stock, debt is impossible and licensing arrangements for such a small company gets rid of its chance of being more valuable.

Share RecommendKeepReplyMark as Last Read
Previous 10 Next 10